In this single-centre prospective study, we therefore sought to evaluate the relationships between plasma NLRP3 inflammasome levels, occludin concentrations, HT and 90-day clinical outcomes in AIS patients, with the goal of determining their individual and complementary prognostic value. This evidence concerns the gene OCLN and androgen insensitivity syndrome.